Wakefit Innovations Limited has announced the approval of 1,72,762 employee stock options under its WAKEFIT ESOP-2019 plan. The company's Nomination and Remuneration Committee (NRC) passed the resolution on March 27, 2026, in compliance with SEBI regulations for share-based employee benefits.

ESOP Grant Details

The stock option grant represents a significant employee incentive initiative by the sleep and home solutions company. The options are structured to align employee interests with long-term company performance and retention objectives.

Vesting and Exercise Framework

The employee stock options follow a structured vesting and exercise timeline designed to encourage long-term employee commitment. The vesting schedule incorporates both time-based and performance-based criteria, subject to continued employment with the company.

Key Vesting Terms:

• Minimum vesting period: 12 months from grant date
• Maximum vesting period: 5 years from grant date
• Exercise window: 1 year from respective vesting date
• Vesting criteria: Time and/or performance-based as per Letter of Grant
• Employment requirement: Continued employment necessary for vesting

Regulatory Compliance and Documentation

The ESOP grant aligns with the Securities and Exchange Board of India (Share Based Employee Benefits & Sweat Equity) Regulations, 2021. Wakefit Innovations has fulfilled all disclosure requirements under Regulation 30 of the SEBI Listing Regulations, ensuring transparency for stakeholders.

The company filed the necessary documentation with both BSE Limited and National Stock Exchange of India Limited. Company Secretary and Compliance Officer Surbhi Sharma signed the regulatory filing, confirming adherence to all applicable guidelines and circular requirements.

Share Conversion Structure

Each granted option provides the right to acquire one equity share of Wakefit Innovations Limited upon exercise. The total potential dilution represents 1,72,762 equity shares, each carrying a face value of Re. 1. The exercise price of Re. 1 per option matches the face value of the underlying equity shares.

The company has made detailed information regarding this ESOP grant available on its investor relations website, ensuring accessibility for all stakeholders and maintaining transparency in its employee compensation practices.

HDFC Mutual Fund has disclosed a substantial acquisition in Wakefit Innovations Limited, increasing its stake to 5.43% of the company's paid-up equity capital. The acquisition was completed through open market purchases on March 23, 2026, in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Acquisition Details

The mutual fund acquired 30,00,000 shares of Wakefit Innovations through open market transactions, representing 0.91% of the company's total share capital. This acquisition increased HDFC Mutual Fund's total holding from 1,49,15,996 shares (4.52%) to 1,79,15,996 shares (5.43%).

Fund Schemes Involved

The acquisition was made through three HDFC Mutual Fund schemes managed by HDFC Trustee Company Limited:

• HDFC Children's Fund
• HDFC Consumption Fund
• HDFC Small Cap Fund

HDFC Asset Management Company Limited, acting as investment manager for HDFC Mutual Fund, confirmed that the fund house does not belong to the promoter or promoter group of Wakefit Innovations.

Regulatory Compliance and Disclosure

The disclosure was made by Dinesh Bhakade, Deputy Vice President - Compliance at HDFC Asset Management Company Limited, on March 25, 2026. The notification was sent to Wakefit Innovations' Company Secretary Ms. Surbhi Sharma and copied to the listing departments of both BSE Limited and National Stock Exchange of India Limited.

Company Profile

Wakefit Innovations Limited has a paid-up equity capital of Rs. 32,99,66,749, comprising 32,99,66,749 equity shares of Rs. 1 each. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited.

The acquisition did not involve any shares in the nature of encumbrance, voting rights other than equity shares, or convertible securities. All acquired shares carry voting rights and were purchased through regular open market transactions.